SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

COHEN ARAZI, Hernán et al. Relación entre el efecto antiagregante de la aspirina y el recuento plaquetario: Posibles implicaciones en la dosificación. Rev. argent. cardiol. [online]. 2012, vol.80, n.2, pp. 114-120. ISSN 1850-3748.

    1. Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR. Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ 2008;336:195-8. [ Links ]

    2. Cohen Arazi H, Doiny DG, Spampinato Torcivia R, Grancelli H, Waldman SV, Nojek C, et al. Impaired anti-platelet effect of aspirin, inflammation and platelet turnover in cardiac surgery. Interact Cardiovasc Thorac Surg 2010;10:863-7. [ Links ]

    3. Golanski J, Chlopicki S, Golanski R, Gresner P, Iwaszkiewicz A, Guatala C. Resistance to aspirin in patients after coronary artery bypass grafting is transient: impact on the monitoring of aspirin antiplatelet therapy. Ther Drug Monit 2005;27:484-90. [ Links ]

    4. Lev EI. Aspirin resistance. Transient laboratory finding or important clinical entity? (editorial comment). J Am Coll Cardiol 2009;53:678-80. [ Links ]

    5. Stein PD, Schunemann HJ, Dalen JE, Gutterman D. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126:600-8. [ Links ]

    6. Zimmermann N, Kienzle P, Weber AA, Winter J, Gams E, Schror K, et al. Aspirin resistance after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2001;121:982-4. [ Links ]

    7. Awtry EH, Loscalzo J. Aspirin. Circulation 2000;101:1206-18. [ Links ]

    8. Folman CC, Ooms M, Kuennen B, De Jong SM, Vet RJ, Haas M, et al. The role of thrombopoietin in post-operative thrombocytosis. Br J Haematol 2001;114:126-33. [ Links ]

    9. Zimmermann N, Gams E, Hohlfeld T. Aspirin in coronary artery bypass surgery: new aspects of an alternatives for an old antithrombotic agent. Eur J Cardiothorac Surg 2008;34:93-108. [ Links ]

    10. Kaser A, Brandacher G, Steurer W, Kaser S, Offner FA, Zoller H, et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 2001;98:2720-5. [ Links ]

    11. Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet 2006;367:606-17. [ Links ]

    12. Zimmermann N, Wenk A, Kim U, Kienzle P, Weber AA, Gams S, et al. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery. Circulation 2003;108:542-7. [ Links ]

    13. Maree AO, Curtin RJ, Dooley M, Conroy RM, Crean P, Cox D, et al. Platelet response to low-dose enteric coated aspirin in patients with stable cardiovascular disease. J Am Coll Cardiol 2005;46:1258-63. [ Links ]

    14. Grove EL, Hvas AM, Mortensen SB, Larsen, SB, Kristensen D. Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease. J Thromb Haemost 2010;9:185-91. [ Links ]

    15. Henry P, Vermillet A, Boval B, Guyetand C, Petroni T, Dillinger JG, et al. 24-hour-time-dependent aspirin efficacy in patients with stable coronary artery disease. Thromb Haemost 2011;105:336-44. [ Links ]

    16. Anfossi G, Russo I, Trovati M. Resistance to aspirin and thienopyridines in diabetes mellitus and metabolic syndrome. Curr Vasc Pharmacol 2008;6:313-28. [ Links ]

    17. Zimmermann N, Kurt M, Winter J, Gams E, Wenzel F, Hohlfeld T. Detection and duration of aspirin resistance after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2008;135:947-8. [ Links ]

    18. Hamberg M, Svensson J, Samuelsson B. Thromboxane: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 1975;72:2994-8. [ Links ]

    19. Fuster V, Sweeny M. Aspirin: a historical and contemporary therapeutic overview. Circulation 2011;123:768-78. [ Links ]

    20. Di Minno G, Silver MJ, Murphy S. Monitoring the entry of new platelets into the circulation after the ingestion of aspirin. Blood 1983,61:1081-5. [ Links ]

    21. Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low dose aspirin in healthy subjects. J Clin Invest 1982,69:1366-72. [ Links ]

    22. Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003;75:715-20. [ Links ]

    23. Zimmermann N, Kurt M, Wenk A, Winter J, Gams E, Hohlfeld T. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting? Eur J Cardiothorac Surg 2005;27:606-10. [ Links ]

    24. Santilli F, Rocca B, De Cristofaro R, Lattanzio S, Pietrangelo L, Habib A, et al. Platelet cyclooxigenase inhibition by low dose aspirin is not reflected by platelet function assays: implications for aspirin "resistance". J Am Coll Cardiol 2009;53:667-77. [ Links ]

    25. Guthikonda S, Alviar CL, Vaduganathan M, Arikan M, Tellez A, DeLao T, et al. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol 2008;52:743-9. [ Links ]

    26. Michelson AD. Platelet function testing in cardiovascular diseases. Circulation 2004;110:489-93. [ Links ]